Zileuton is an asthma drug. It blocks leukotriene synthesis by inhibiting 5-lipoxygenase, an enzyme of the eicosanoid synthesis pathway.

Zileuton is marketed by Critical Therapeutics under the brand name Zyflo.

External links

• Zyflo (manufacturer's website)
• Zileuton (patient information)

Leukotriene pathway inhibitors